| 1 |
33869655 | Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A. | 2021 Jun 11 |
1 |
| 2 |
34795305 | VEGF-A, PDGF-BB and HB-EGF engineered for promiscuous super affinity to the extracellular matrix improve wound healing in a model of type 1 diabetes. | 2021 Nov 18 |
1 |
| 3 |
26032846 | Coacervate delivery of HB-EGF accelerates healing of type 2 diabetic wounds. | 2015 Jul-Aug |
2 |
| 4 |
23793991 | Omeprazole and PGC-formulated heparin binding epidermal growth factor normalizes fasting blood glucose and suppresses insulitis in multiple low dose streptozotocin diabetes model. | 2013 Nov |
1 |
| 5 |
17544586 | Depolarization-induced, glutamate receptor-mediated, and transactivation-dependent extracellular-signal regulated kinase phosphorylation in cultured cerebellar granule neurons. | 2007 Jun 29 |
1 |
| 6 |
15557365 | Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. | 2004 Dec 7 |
1 |
| 7 |
9729296 | Opposing actions of the EGF family and opioids: heparin binding-epidermal growth factor (HB-EGF) protects mouse cerebellar neuroblasts against the antiproliferative effect of morphine. | 1998 Aug 31 |
1 |
| 8 |
7706382 | Carboxyl-terminal truncation of leucine76 converts heparin-binding EGF-like growth factor from a heparin-enhancible to a heparin-suppressible growth factor. | 1995 May |
9 |
| 9 |
7706383 | Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity. | 1995 May |
5 |